International Journal of Colorectal Disease

, Volume 34, Issue 4, pp 569–580 | Cite as

Endoscopic detection and resection of dysplasia in inflammatory bowel disease-techniques with videos

  • Sameen Khalid
  • Aamer Abbass
  • Neelam Khetpal
  • Bo Shen
  • Udayakumar NavaneethanEmail author



Patients with ulcerative colitis and Crohn’s colitis have an increased risk of developing dysplasia and colorectal cancer as compared to the general population; surveillance colonoscopy is recommended in this patient population.


This review of the published literature aimed to assess the published evidence.


Detection of dysplasia requires examination of mucosa with targeted biopsies of the visible lesions as well as random biopsies to detect invisible lesions. Newer endoscopic techniques, in particular chromoendoscopy, increase the yield of identifying dysplastic lesions. The surveillance for Colorectal Endoscopic Neoplasia Detection and Management in Inflammatory Bowel Disease Patients International Consensus (SCENIC) guidelines recommends that colonoscopy using chromoendoscopy is the optimal endoscopic surveillance strategy to detect dysplasia. Once dysplastic lesions are discovered on surveillance endoscopic examination, careful and meticulous descriptions of lesions is mandatory to aid in further decision making. Management of dysplastic lesions in inflammatory bowel disease patients depends on endoscopic (morphological) and histologic findings and patient characteristics such as age, general condition of the patient, and patient preferences. Endoscopic mucosal resection, endoscopic submucosal dissection, and surgery are different therapeutic options for colonic dysplastic lesions detected in the setting of inflammatory bowel disease.


In this review, we discuss the various techniques for endoscopic resection of dysplasia in patients with inflammatory bowel disease. Further research is required to determine the optimal approach to diagnosis and management of dysplasia in patients with inflammatory bowel disease.


Chromoendoscopy Dysplasia Endoscopic mucosal resection Inflammatory bowel disease Ulcerative colitis 


Author contributions

Study concept, design, and critical revisions—B Shen and U Navaneethan

Paper preparation and revisions—S Khalid, N Khetpal, and A Abbass

Compliance with ethical standards

Conflict of interest

Udayakumar Navaneethan and Bo Shen are consultants for AbbVie. Udayakumar Navaneethan is on the speaker bureau for Takeda, AbbVie, Pfizer, and Janssen. None of the other authors declared financial conflict of interest.

Supplementary material

384_2019_3269_MOESM1_ESM.mp4 (1.3 mb)
Video 1 Video demonstrates the technique of chromoendoscopy. (MP4 1322 kb)
384_2019_3269_MOESM2_ESM.mp4 (3.2 mb)
Video 2 Video demonstrates the technique for resection of a polypoid lesion in a patient with Crohn’s colitis. (MP4 3270 kb)


  1. 1.
    Laine L et al (2015) SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 81(3):489–501.e26. CrossRefGoogle Scholar
  2. 2.
    Uraoka T, Parra-Blanco A, Yahagi N (2013) Colorectal endoscopic submucosal dissection: is it suitable in Western countries? J Gastroenterol Hepatol 28(3):406–414CrossRefGoogle Scholar
  3. 3.
    Shergill A, Lightdale J, Bruining D et al (2015) The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc 81(5):11011121.e5 CrossRefGoogle Scholar
  4. 4.
    Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S, on behalf of the IBD Section of the British Society of Gastroenterology (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut. 60:571–607CrossRefGoogle Scholar
  5. 5.
    Farraye FA, Odze RD, Eaden J et al (2010) AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 138:746–774 74 e1–4CrossRefGoogle Scholar
  6. 6.
    Itzkowitz SH, Present DH, Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group (2005) Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11:314–321CrossRefGoogle Scholar
  7. 7.
    Kornbluth A, Sachar DB (2010) Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 105:501–523CrossRefGoogle Scholar
  8. 8.
    Wanders LK, Dekker E, Pullens B, Bassett P, Travis SPL, East JE (2014) Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterol Hepatol 12(5):756–764CrossRefGoogle Scholar
  9. 9.
    Iacucci M, Uraoka T, Gasia MF, Yahagi N (2014) Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol 28(7):361–370CrossRefGoogle Scholar
  10. 10.
    Jess T, Rungoe C, Peyrin-Biroulet L (2012) Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 10:639–645CrossRefGoogle Scholar
  11. 11.
    Bleday R, Lee E, Jessurun J, Heine J, Wong DW (1993) Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 36:908–912CrossRefGoogle Scholar
  12. 12.
    Ullman T, Odze R, Farraye FA (2009) Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn’s disease of the colon. Inflamm Bowel Dis 15(4):630–638. CrossRefGoogle Scholar
  13. 13.
    Andersen NN, Jess T (2013) Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol 43:7561–7568CrossRefGoogle Scholar
  14. 14.
    Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun–Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR (2013) Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol 11:1601–1608CrossRefGoogle Scholar
  15. 15.
    Holt B, Bourke M (2012) Wide field endoscopic resection for advanced colonic mucosal neoplasia: current status and future directions. Clin Gastroenterol Hepatol 10:969–979CrossRefGoogle Scholar
  16. 16.
    Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-Lewis L, Gerdes H, Stewart ET (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329:1977–1981CrossRefGoogle Scholar
  17. 17.
    Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366:687–696CrossRefGoogle Scholar
  18. 18.
    Howdle P, Atkin W, Rutter M (2011) Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas. In: National Institute for Health and Clinical Excellence (NICE) clinical guideline 118. National Institute for Health and Clinical Excellence, LondonGoogle Scholar
  19. 19.
    Farraye FA, Odze RD, Eaden J et al (2010) AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 138:738–745CrossRefGoogle Scholar
  20. 20.
    Eaden JA, Mayberry JF (2002) Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut. 51:V10–V12CrossRefGoogle Scholar
  21. 21.
    Itzkowitz SH, Harpaz N (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 126:1634–1648CrossRefGoogle Scholar
  22. 22.
    Loftus EV Jr (2006) Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Gastroenterol Clin N Am 35:517–531CrossRefGoogle Scholar
  23. 23.
    Jess T, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, Schleck CD, Tremaine WJ, Melton LJ III, Munkholm P, Sandborn WJ (2006) Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 130:1039–1046CrossRefGoogle Scholar
  24. 24.
    East JE, Toyonaga T, Suzuki N (2014) Endoscopic management of nonpolypoid colorectal lesions in colonic IBD. Gastrointest Endosc Clin N Am 24:435–445CrossRefGoogle Scholar
  25. 25.
    Leighton JA, Shen B, Baron TH, Adler DG, Davila R, Egan JV, Faigel DO, Gan SI, Hirota WK, Lichtenstein D, Qureshi WA, Rajan E, Zuckerman MJ, VanGuilder T, Fanelli RD, Standards of Practice Committee, American Society for Gastrointestinal Endoscopy (2006) ASGE guidelines: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc 63:558–565CrossRefGoogle Scholar
  26. 26.
    Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J (2000) Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 14:145–153CrossRefGoogle Scholar
  27. 27.
    Eaden J, Ward BA, Mayberry JF (2000) How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 51:123–128CrossRefGoogle Scholar
  28. 28.
    Xie J, Itzkowitz SH (2008) Cancer in inflammatory bowel disease. World J Gastroenterol 14(3):378–389CrossRefGoogle Scholar
  29. 29.
    Burgess NG, Hourigan LF, Zanati SA, Brown GJ, Singh R, Williams SJ, Raftopoulos SC, Ormonde D, Moss A, Byth K, Mahajan H, McLeod D, Bourke MJ (2017) Risk stratification for covert invasive cancer among patients referred for colonic endoscopic mucosal resection: a large multicenter cohort. Gastroenterology. 153:732–742CrossRefGoogle Scholar
  30. 30.
    Kiesslich R, Neurath MF (2006) Chromoendoscopy and other novel imaging techniques. Gastroenterol Clin N Am 35:605–619CrossRefGoogle Scholar
  31. 31.
    Soetikno R, Sanduleanu S, Kaltenbach T (2014) An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease. Gastrointest Endosc Clin N Am 24:483–520CrossRefGoogle Scholar
  32. 32.
    Soetikno R, Subramanian V, Kaltenbach T et al (2013) The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 144:1349–1352 52 e1–6CrossRefGoogle Scholar
  33. 33.
    Murthy SK, Kiesslich R (2013) Evolving endoscopic strategies for detection and treatment of neoplastic lesions in inflammatory bowel disease. Gastrointest Endosc 77:351–359CrossRefGoogle Scholar
  34. 34.
    Van Assche G, Dignass A, Bokemeyer B et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7:1–33CrossRefGoogle Scholar
  35. 35.
    Ekbom A, Helmick C, Zack M et al (1990) Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 336:357–359CrossRefGoogle Scholar
  36. 36.
    Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228–1233CrossRefGoogle Scholar
  37. 37.
    Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN (1994) Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35:1590–1592CrossRefGoogle Scholar
  38. 38.
    Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, Bodian C, Ullman T (2007) Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133:1099–1105 quiz 340-1CrossRefGoogle Scholar
  39. 39.
    Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, Lofberg R, Brostrom O, Hellers G (1988) Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 29:206–217CrossRefGoogle Scholar
  40. 40.
    Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126:451–459CrossRefGoogle Scholar
  41. 41.
    Kiesslich R, Fritsch J, Holtmann M, Koehler HH, Stolte M, Kanzler S, Nafe B, Jung M, Galle PR, Neurath MF (2003) Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 124:880–888CrossRefGoogle Scholar
  42. 42.
    Subramanian V, Mannath J, Ragunath K, Hawkey CJ (2011) Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 33:304–312CrossRefGoogle Scholar
  43. 43.
    Konijeti GG, Shrime MG, Ananthakrishnan AN, Chan AT (2014) Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc 79:455–465CrossRefGoogle Scholar
  44. 44.
    Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, Ferrante M, Götz M, Katsanos KH, Kießlich R, Ordás I, Repici A, Rosa B, Sebastian S, Kucharzik T, Eliakim R, European Crohn's and Colitis Organisation (2013) European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 7:982–1018CrossRefGoogle Scholar
  45. 45.
    Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, Eaden JA, Rutter MD, Atkin WP, Saunders BP, Lucassen A, Jenkins P, Fairclough PD, Woodhouse CR, British Society of Gastroenterology, Association of Coloproctology for Great Britain and Ireland (2010) Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 59:666–689CrossRefGoogle Scholar
  46. 46.
    Jegadeesan R, Navaneethan U, Gutierrez NG, Venkatesh PGK, Hammel JP, Sanaka MR, Shen B (2016) Pattern of inflammation on surveillance colonoscopy does not predict development of colitis-associated neoplasia. Inflamm Bowel Dis 22:2221–2228CrossRefGoogle Scholar
  47. 47.
    Mahmoud R, Shah SC, Ten Hove JR et al (2018) No association between pseudopolyps and colorectal neoplasia in patients with inflammatory bowel diseases. Gastroenterology.
  48. 48.
    Moussata D, Allez M, Cazals-Hatem D et al (2017) Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut.
  49. 49.
    Viera AJ (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37:360–365Google Scholar
  50. 50.
    Berho M, Allende DJ (2014) The Role of the Pathologist in the Diagnosis and Treatment of Dysplasia in Inflammatory Bowel Disease. Gastrointest Surg 18:1231–1233CrossRefGoogle Scholar
  51. 51.
    Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, Gastrointestinal Consortium Panel (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 124:544–560CrossRefGoogle Scholar
  52. 52.
    Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R, East JE, Farraye FA, Feagan B, Ioannidis J, Kiesslich R, Krier M, Matsumoto T, McCabe RP, Mönkemüller K, Odze R, Picco M, Rubin DT, Rubin M, Rubio CA, Rutter MD, Sanchez-Yague A, Sanduleanu S, Shergill A, Ullman T, Velayos F, Yakich D, Yang YX (2015) SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 148:639–651CrossRefGoogle Scholar
  53. 53.
    Kaltenbach T, Leite G, Soetikno R (2016) Colonoscopy surveillance and management of dysplasia. Curr Treat Options Gastroenterol 14:103–114CrossRefGoogle Scholar
  54. 54.
    Moss A, Bourke MJ, Kwan V, Tran K, Godfrey C, McKay G, Hopper AD (2010) Succinylated gelatin substantially increases en bloc resection size in colonic EMR: a randomized, blinded trial in a porcine model. Gastrointest Endosc 71:589–595CrossRefGoogle Scholar
  55. 55.
    Moss A, Bourke MJ, Metz A (2010) A randomized, double-blind trial of succinylated gelatin sub mucosal injection for endoscopic resection of large sessile polyps of the colon. Am J Gastroenterol 105:2375–2382CrossRefGoogle Scholar
  56. 56.
    Branquinho D, Portela F, Freire P, et al. (2016) P572 dysplasia in inflammatory bowel disease: is endoscopic mucosal resection ready for prime-time? 11th Congress of ECCO. AmsterdamGoogle Scholar
  57. 57.
    Navaneethan U, Feurer M, Villaneuva F, Glover S (2017) Impact of chromoendoscopy on outcomes in inflammatory bowel disease patients with a history of low grade dysplasia on white light endoscopy. Gastrointest Endosc 85:AB611Google Scholar
  58. 58.
    Suzuki N, Toyonaga T, East JE (2017) Endoscopic submucosal dissection of colitis-related dysplasia. Endoscopy. 49:1237–1242. CrossRefGoogle Scholar
  59. 59.
    Iacopini F, Saito Y, Yamada M, Grossi C, Rigato P, Costamagna G, Gotoda T, Matsuda T, Scozzarro A (2015) Curative endoscopic submucosal dissection of large nonpolypoid superficial neoplasms in ulcerative colitis (with videos). Gastrointest Endosc 82(4):734–738CrossRefGoogle Scholar
  60. 60.
    Schmidt A, Beyna T, Schumacher B, Meining A, Richter-Schrag HJ, Messmann H, Neuhaus H, Albers D, Birk M, Thimme R, Probst A, Faehndrich M, Frieling T, Goetz M, Riecken B, Caca K (2018) Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indications. Gut. 67(7):1280–1289CrossRefGoogle Scholar
  61. 61.
    Sameshima S, Koketsu S, Takeshita E, Kubota Y, Okuyama T, Saito K, Ueda Y, Sawada T, Oya M (2015) Surgical resections of ulcerative colitis associated with dysplasia or carcinoma. World J Surg Oncol 13:70CrossRefGoogle Scholar
  62. 62.
    Fazio VW, O’Riordain MG, Lavery IC, Church JM, Lau P, Strong SA, Hull T (1999) Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg 230(4):575CrossRefGoogle Scholar
  63. 63.
    Connelly TM, Koltun WA (2013) The surgical treatment of inflammatory bowel disease-associated dysplasia. Expert Rev Gastroenterol Hepatol 7:307–321 quiz 322CrossRefGoogle Scholar
  64. 64.
    Al-Sukhni W, McLeod RS, MacRae H et al (2010) Oncologic outcome in patients with ulcerative colitis associated with dyplasia or cancer who underwent stapled or handsewn ileal pouch-anal anastomosis. Dis Colon Rectum 53:1495–1500CrossRefGoogle Scholar
  65. 65.
    Selvaggi F, Pellino G, Canonico S, Sciaudone G (2014) Systematic review of cuff and pouch cancer in patients with ileal pelvic pouch for ulcerative colitis. Inflamm Bowel Dis 20:1296–1308CrossRefGoogle Scholar
  66. 66.
    Iacucci M, McQuaid K, Gui XS, Iwao Y, Lethebe BC, Lowerison M, Matsumoto T, Shivaji UN, Smith SCL, Subramanian V, Uraoka T, Sanduleanu S, Ghosh S, Kiesslich R (2019) A multimodal (FACILE) classification for optical diagnosis of inflammatory bowel disease associated neoplasia. Endoscopy. 51:133–141CrossRefGoogle Scholar
  67. 67.
    Sugimoto S, Naganuma M, Iwao Y, Matsuoka K, Shimoda M, Mikami S, Mizuno S, Nakazato Y, Nanki K, Inoue N, Ogata H, Kanai T (2017) Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement. Gastrointest Endosc 85:639–646CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Sameen Khalid
    • 1
  • Aamer Abbass
    • 1
  • Neelam Khetpal
    • 1
  • Bo Shen
    • 2
  • Udayakumar Navaneethan
    • 3
    Email author
  1. 1.Department of Internal MedicineAdvent HealthOrlandoUSA
  2. 2.Department of Gastroenterology Cleveland ClinicClevelandUSA
  3. 3.Center for Interventional Endoscopy, Advent HealthUniversity of Central Florida College of MedicineOrlandoUSA

Personalised recommendations